Aliflurane

In this article we will explore Aliflurane, a topic of great relevance today that impacts various areas of study and that has generated broad interest in the academic community and society in general. Aliflurane represents a crucial point to understand the functioning of different phenomena, from a historical, scientific, social or cultural perspective. Through detailed analysis, we will examine each relevant aspect of Aliflurane, exploring its implications, its evolution over time, as well as possible solutions or approaches to address this challenge. This article aims to offer a comprehensive, critical and reflective vision about Aliflurane, in an effort to provide knowledge and generate an informed debate on this important topic.

Aliflurane
Clinical data
ATC code
  • None
Identifiers
  • 1-Chloro-1,2,2,3-tetrafluoro-3-methoxycyclopropane
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC4H3ClF4O
Molar mass178.51 g·mol−1
3D model (JSmol)
  • COC1(C(C1(F)Cl)(F)F)F
  • InChI=1S/C4H3ClF4O/c1-10-4(9)2(5,6)3(4,7)8/h1H3
  • Key:LZKANMYVPJZLEW-UHFFFAOYSA-N

Aliflurane (code name Hoechst Compound 26 or 26-P) is a halocarbon drug which was investigated as an inhalational anesthetic but was never marketed.[1][2][3][4]

See also

References

  1. ^ World Health Organization (1988). International Nonproprietary Names (INN) for Pharmaceutical Substances. W.H.O. ISBN 9789240560369.
  2. ^ Banks RE, Smart BE, Tatlow JC (30 September 1994). Organofluorine Chemistry: Principles and Commercial Applications. Springer Science & Business Media. pp. 550–. ISBN 978-0-306-44610-8.
  3. ^ Kirsch P (6 March 2006). Modern Fluoroorganic Chemistry: Synthesis, Reactivity, Applications. John Wiley & Sons. pp. 263–. ISBN 978-3-527-60419-7.
  4. ^ Kaushik (1995). Anaesthesia:Concepts and Management. Jaypee Brothers Publishers. pp. 124–. ISBN 978-81-7179-406-5.